ICYMI: Highlights From ESC Congress 2023
Two major trials presented at the European Society of Cardiology (ESC) 2023 Congress were the STEP-HFpEF and FRAIL-AF trials.
Stay updated with breaking news from Esc Congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two major trials presented at the European Society of Cardiology (ESC) 2023 Congress were the STEP-HFpEF and FRAIL-AF trials.
The risk of bleeding increased by about 60% in the oldest and frailest patients who were shifted from a VKA compared to those who stayed on the conventional medication.A new study presented at the...
Results of the FRAIL-AF trial at ESC Congress 2023 provide clinicians with further clarity into the effects of switching from vitamin K antagonists to NOACs in older patients with frailty and atrial fibrillation.
Less than 2 weeks after the release of their SELECT reaction podcast, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down for a special edition episode of Diabetes Dialogue to discuss STEP-HFpEF data and the implications for semaglutide 2.4 mg.
The latest study by the European Society of Cardiology has found an association between not taking aspirin after a heart attacks and increased risk of